Mycobacterium tuberculosis produces a large number of structurally diverse lipids that have been implicated in the pathogenicity, persistence and antibiotic resistance of this organism. Most building blocks involved in the biosynthesis of all these lipids are generated by acyl-CoA carboxylases whose subunit composition and physiological roles have not yet been clearly established. Inconclusive data in the literature refer to the exact protein composition and substrate specificity of the enzyme complex that produces the long-chain a-carboxy-acyl-CoAs, which are substrates involved in the last step of condensation mediated by the polyketide synthase 13 to synthesize mature mycolic acids. Here we have successfully reconstituted the long-chain acyl-CoA carboxylase (LCC) complex from its purified components, the a subunit (AccA3), the e subunit (AccE5) and the two b subunits (AccD4 and AccD5), and demonstrated that the four subunits are essential for its activity. Furthermore, we also showed by substrate competition experiments and the use of a specific inhibitor that the AccD5 subunit's role in the carboxylation of the long acyl-CoAs, as part of the LCC complex, was structural rather than catalytic. Moreover, AccD5 was also able to carboxylate its natural substrates, acetyl-CoA and propionyl-CoA, in the context of the LCC enzyme complex. Thus, the supercomplex formed by these four subunits has the potential to generate the main substrates, malonyl-CoA, methylmalonyl-CoA and a-carboxy-C 24-26 -CoA, used as condensing units for the biosynthesis of all the lipids present in this pathogen.
Introduction
The hallmark of Mycobacterium tuberculosis is its unusual lipid-rich cell envelope that contains several components essential for its viability and pathogenicity. This highly impermeable barrier imparts resistance to both hostile environments and therapeutic agents, and plays an active role in modulating the host immune response [1, 2] . Thus, the unique structure of this cell envelope and the importance of its integrity for the viability of the organism imply that enzymes involved in its biosynthesis could be good targets for the development of novel therapeutic agents. For instance, the front-line antitubercular drug isoniazid (INH) has as a target InhA, the 2-trans-enoyl-acyl carrier protein reductase of the type II fatty acid synthase involved in the biosynthesis of the major lipid components of the mycobacteria outer membrane, the mycolic acids [3] . Following this rationale, the acyl-CoA carboxylases (ACCases), enzymes that provide the building blocks for fatty acids, mycolic acids and complex lipids in mycobacteria, could also be considered as potential targets for the development of new antituberculosis drugs [4, 5] .
ACCases are ubiquitous multifunctional enzymes that catalyze the biotin-dependent carboxylation of coenzyme A esters, in which the site for carboxylation is either the a-carbon position of saturated acid esters, such as acetyl-CoA, propionyl-CoA and long-chain acyl-CoAs, or the c-carbon position of a-b unsaturated acid esters [6] . The carboxylation reaction occurs in two catalytic steps [7] : first, the biotin carboxylase (BC) couples carbonate to a biotin residue attached to a biotin carboxyl carrier protein (BCCP) to form carboxybiotin; second, the carboxyltransferase (CT) transfers the carboxyl group from biotin to the acylCoA and generates the corresponding carboxylated acyl-CoA.
In actinomycetes, the ACCases are generally organized into oligomeric assemblies composed of two different subunits: an a subunit that contains the BC and the BCCP domains, and a b subunit that contains the CT domain [8] [9] [10] [11] [12] . A third subunit, called e, a unique feature of actinomycetes, has been found to be essential for holo complex activity of only some of the ACCase complexes characterized so far [13, 14] . In M. tuberculosis, three a subunit-encoding (accA1-3), six b subunit-encoding (accD1-6) and one e subunitencoding (accE5) genes have been identified [14] . However, despite the high number of putative ACCase subunits present in this microorganism, to date, only one c-acyl-CoA carboxylase, formed by the AccA1 and AccD1 subunits [15] , and two a-acyl-CoA carboxylase enzyme complexes have been thoroughly characterized at the biochemical and physiological levels. The two a-ACCases are ACCase 6, which was successfully reconstituted in vitro from the biotinylated a subunit AccA3 and the b subunit AccD6 [16] [17] [18] , and ACCase 5, reconstituted from the a subunit AccA3, the b subunit AccD5 and the e subunit AccE5 [14, 19] . These two enzyme complexes are able to carboxylate both acetyl-CoA and propionyl-CoA; however, enzyme kinetic studies demonstrated that ACCase 6 has a substrate preference towards acetylCoA, while ACCase 5 preferentially carboxylates propionyl-CoA [14, 16] . These results, together with the physiological analysis of conditional mutants in the essential accD6 and accD5 genes, have determined that in vivo ACCase 6 functions as an acetyl-CoA carboxylase (ACC) that generates malonyl-CoA, the main building block for straight-chain fatty acids biosynthesis, including mycolic acids, while ACCase 5 would be, most probably, the propionyl-CoA carboxylase (PCC) that synthesizes methylmalonyl-CoA for the biosynthesis of methyl-branched lipids of the mycobacterial envelope [14, 19] .
Until now there has been no conclusive biochemical or physiological evidence regarding the precise protein composition and/or specific role of each of the subunits proposed to be part of the long-chain acyl-CoA carboxylase (LCC), the enzyme complex involved in the a-carboxylation of the very long-chain acyl-CoAs (C 24 -C 26 ) prior to their condensation with a C 50 -C 60 meromycolic acid by polyketide synthase 13 (Pks13) to produce mycolic acids. Genetic and biochemical studies carried out with an enzyme complex purified from Corynebacterium glutamicum suggested that the LCC enzyme could have a fairly complex subunit composition in this and other actinomycetes. In this regard, an enzyme complex containing two CT subunits, AccD3 (an ortholog of AccD4 of M. tuberculosis whose gene is genetically linked to pks13) and AccD2 (an ortholog of AccD5 of M. tuberculosis), the a subunit AccBC (an ortholog of AccA3 of M. tuberculosis) and the e subunit AccE was purified from C. glutamicum. This complex, containing a rather unique protein composition, showed carboxylase activity against C 16 -CoA, to produce the a-carboxylated-C 16 -CoA for the biosynthesis of corynomycolic acids [20, 21] . However, these studies did not explore the essentiality or the specific role of each of the protein subunits in the enzyme complex activity. On the other hand, the limited studies performed on the mycobacterial LCC bring more uncertainty into this issue. For example, co-immunoprecipitation experiments carried out in cell-free extracts of Mycobacterium smegmatis showed that using an antibody against a tagged AccD4 resulted in coprecipitation of AccD4 with the AccA3 and AccD5 subunits [22] . A second study, carried out using singlestep avidin chromatography, led to the purification of a complex containing the biotinylated subunit AccA3, the b subunits AccD4 and AccD5, and the e subunit AccE5 from M. smegmatis; however, no activity assays were performed with the purified complex [23] . Interestingly, the same work also reported that LCC activity was reconstituted in vitro in the presence of both AccA3 and AccD4 subunits, while the e subunit AccE5 partially inhibited this enzyme activity. Surprisingly, the specific activities were about 500 times lower compared with those obtained for other reconstituted mycobacterial ACC complexes, and 100 times lower than the values obtained for the C. glutamicum LCC [21, 23] . More recent studies carried out with cell-free extracts prepared from a conditional AccD5 mutant of M. smegmatis showed both a reduction in the bacterial LCC activity and a decrease in the carboxy-C 24 -CoA content when accD5 expression was decreased, suggesting that AccD5 could also play an active role in the LCC complex [19] . Taking all these data into consideration, it is clear that the evidence is still inconclusive in terms of the subunits that form part of the LCC enzyme in mycobacteria and the role that each subunit has in this enzyme complex, essential for the synthesis of mycolic acids and for the survival of these organisms.
In the present study, we report the successful in vitro reconstitution of the LCC of M. tuberculosis from its purified subunits, and determine the specific role that each of the b subunits, AccD4 and AccD5, plays in this enzyme complex. We also present data for the kinetic parameters for the preferred substrates of this holocomplex and provide strong evidence that the LCC enzyme of mycobacteria is a supercomplex with the ability to carboxylate different chain length acylCoAs, which could potentially provide the substrates needed for fatty acid and mycolic acid biosynthesis, as well as for methyl-branched lipid biosynthesis.
Results

Dissection of the subunit composition of the LCC enzyme complex of Mycobacterium tuberculosis
The existing data relating to the subunit composition, the substrate specificity and role of each of the b subunits present in the so-called LCC enzyme complex of mycolic acid containing actinomycetes, remain poorly characterized in mycobacteria. The main difference between the C. glutamicum and the M. tuberculosis LCC complexes is the minimal set of subunits that each of them appears to require in order to carboxylate their corresponding long-chain acyl-CoA substrate [20, 22, 23] . Therefore, in the first part of this work we aimed to determine the minimal set of subunits that compose the LCC enzyme complex of M. tuberculosis.
With these precedents and with the aim of studying the biochemistry of the enzyme complex responsible of synthesizing the a-carboxy-C 24-26 -CoA in M. tuberculosis, the precursors of the a alkyl-chain of mycolic acids, we developed a liquid chromatographymass spectrometry (LC-MS) method to efficiently and reproducibly assay LCC activity in vitro. For this, the four subunits proposed to be part of the LCC enzyme complex of M. tuberculosis were independently expressed in Escherichia coli as N-terminal His-tagged proteins and purified by Ni 2+ affinity chromatography (Fig. 1A) . The oligomeric state of the purified AccD4 and AccD5 subunits was analyzed by size exclusion chromatography and it was found that both proteins are hexamers (Fig. 1B) [14] . The in vitro reconstitution of the LCC enzyme complex was tested by mixing the four purified subunits in an arbitrary AccA3 : AccD4 : AccD5 : AccE5 molar ratio of 1 : 1 : 1 : 4 (and the LCC activity assayed in the presence of 40 lM of C 20 -CoA as the enzyme substrate. The enzymatic reaction was carried out at 30°C for 4 h and the reaction mixes analyzed by LC-MS (Fig. 2) (Fig. 2B ). The identity of the carboxy-C 20 -CoA was further supported by tandem mass spectrometry analysis of the charged ion at m/z 1104.40 (Fig. 2C) . The only combination of subunits that generated the carboxy-C 20 -CoA was the one containing a mix of AccA3, AccD4, AccD5 and AccE5 proteins, while the absence of any of these subunits provoked a total loss of the long-chain acyl-CoA carboxylase activity of the complex ( Fig. 2A) . These results showed, for the first time, that the four subunits are essential, at least in vitro, for the reconstitution of an active LCC enzyme complex. However, the fact that AccD5 and AccE5 have been previously characterized as the b and e subunits of an essential ACCase involved in the carboxylation of propionyl-CoA and acetyl-CoA (ACCase 5) [14] , now opens the question of a putative new role of the AccD5 and AccE5 proteins in the context of the LCC enzyme complex.
Once the minimal set of proteins necessary to generate LCC activity in vitro was determined, the optimal molar ratio of the four subunits was studied by combining various molar concentrations of the individual proteins and then carrying out the enzyme assay described above. As seen in Fig. 3A , we achieved the highest carboxylase activities towards C 20 -CoA when the AccA3 : AccD4 : AccD5 : AccE5 molar ratio was 1 : 1 : 1 : 2, respectively. Increasing the molar ratio of AccE5 above 2 or of any of the other LCC subunits above 1 did not improve the specific enzyme activity. Based on these results, we used the molar ratio indicated above for the rest of the study.
Substrate specificity of the LCC complex
Following the enzymatic characterization of the LCC complex, and in order to determine the tolerance of this enzyme for different chain-length acyl-CoAs, we carried out enzyme assays in the presence of C 8 -, C 16 -, C 18 -, C 20 -and C 24 -CoA, each of them at 40 lM. Carboxylase activity was detected with all the long-chain substrates assayed (C 16 -C 24 ), although at very different levels, revealing a high degree of substrate tolerance for this enzyme complex (Fig. 3B) . Unexpectedly, the highest specific activity was obtained with C 20 -CoA, and not with the supposedly preferred substrates of this enzyme, C 24 -CoA and C 26 -CoA, whose a-carboxy derivatives become the major a-alkyl chains of the mycolic acids present in M. tuberculosis, after their condensation with the meromycolyl-AMP by Pks13. This result could be explained by the detergent properties of such long-chain B A Fig. 1 . Purification and analysis of the LCC subunits. (A) Purification of LCC subunits. Each His-tagged protein was purified as described in Gago et al. [14] . Fractions highlighted in red were collected, dialyzed and used for further experiments; 12% Tris/glycine SDS/PAGE was used for AccA3, AccD4 and AccD5, and 18% Tris/tricine SDS/PAGE for AccE5. P, pellet fraction; FT, flow through; MMM, molecular mass marker. (B) Determination of the oligomeric state of the carboxyltransferase b subunits, AccD5 and AccD4. The protein profiles (A 280 nm in milli-absorbance units; mAU) and molecular masses of protein standards used are shown. The calibration curve is shown in the inset. acyl-CoAs at the concentration tested (40 lM), which could inhibit the enzyme activity. However, when C 20 -CoA and C 24 -CoA were added to the same reaction mix at 40 lM each, carboxy-C 20 -CoA was generated at the same levels as in the absence of C 24 -CoA, suggesting that the enzyme remains fully active in the presence of both substrates (Fig. 3C ). One possible explanation for this result is that acyl-CoA substrates > C 20 may not become completely available to the enzyme in the conditions set up for the assay due to their low solubility. Furthermore, when a mix of substrates (C 18 -CoA, C 20 -CoA and C 24 -CoA), each of them at a final concentration of 40 lM, were incubated in the same reaction mix we were able to identify the corresponding carboxyacyl-CoA for each of the substrates present in the reaction mix (Fig. 4) . These results not only highlight the high degree of substrate tolerance for this enzyme complex, but open the question of how the LCC can select the very long-chain acyl-CoAs (C 24 -CoA and C 26 -CoA) in vivo.
Kinetic parameters for the preferred LCC substrates
Since the LCC complex intrinsically contains the ACCase 5 (PCC) enzyme subunits (AccA3, AccD5 and AccE5), we proceeded to determine the kinetic parameters for the substrates of the two radically different ( Table 1 ). The kinetic values obtained for the two short-chain acyl-CoAs were very similar to those obtained for the PCC complex itself (Table 1 ) [14] . The K cat /K m values determine that the catalytic efficiency of the complex for the C 20 -CoA is 10-and 50-fold lower compared with that of acetyl-CoA and propionyl-CoA, respectively. These results suggest that the four subunits that form the LCC complex would carboxylate efficiently, and probably independently, short-chain acyl-CoAs to synthesize the substrates for straight-or branched-chain fatty acid biosynthesis, as well as the long-chain acyl-CoAs for the synthesis of the a-alkyl branch of mycolic acids.
Role of AccD5 in the LCC complex of Mycobacterium tuberculosis
Considering that CTs are the protein subunits that determine the substrate specificity of the ACCases [5] , and based on the biochemical and structural studies that show the high specificity of AccD5 for acetyl-and propionyl-CoA, at least in the context of the PCC complex [14, 24] , we asked ourselves if the role of AccD5 in the carboxylation of long-chain acyl-CoAs by the LCC enzyme was catalytic or structural. To solve this question, we conducted a series of experiments. Firstly, a classical substrate competition assay was performed, and for that, a reaction mix containing AccA3, AccD4, AccD5 and AccE5 was incubated in the presence of C 20 -CoA at 40 lM (the K m for this substrate) and different concentrations of propionylCoA (0, 40 lM and 1 mM). In this context, if the two main activities of the LCC complex function independently, AccD5 together with the other subunits of the ACCase 5 complex (AccA3 and AccE5), should carboxylate its natural substrate propionyl-CoA, while AccD4 should carry out the carboxylation of the C 20 -CoA. On the other hand, if AccD5 is also involved in the catalytic carboxylation of C 20 -CoA, this latter reaction should be competitively inhibited by the presence of up to 1 mM propionyl-CoA (a concentration 6.5-fold its K m ) in the reaction mix. Analysis of the chromatograms showed that the same levels of C 20 -CoA carboxylase activity were found for the three different conditions tested, as if C 20 -CoA were the only substrate present in the reaction mix (Fig. 5A) . Moreover, the 40 lM of propionyl-CoA present in the assay was completely converted into methylmalonyl-CoA at the end of the reaction, while approximately half of the propionyl-CoA remained at the end of the enzyme reaction when it was present at 1 mM concentration in the enzyme assay (Fig. 5A ). This result indicates that there is no competition between these two substrates and that each b subunit that forms part of the LCC complex catalyses the carboxylation of its own substrate; AccD4 carboxylates C 20 -CoA while AccD5 carboxylates propionyl-CoA yielding a-carboxy C 20 -CoA and methylmalonyl-CoA, respectively. A second experiment to determine the independent activity of the two CT subunits present in the LCC complex was carried out with an AccD5 inhibitor recently identified through a high-throughput screening method. The compound, named D5-6, was found to interact with AccD5 and we first tested its inhibitory effect on the propionyl-CoA carboxylase activity of the ACCase 5 complex. In a typical ACCase coupled reaction, the D5-6 compound showed a 90% inhibition of PCC activity at a concentration of 10 lM. The inhibitory effect of D5-6 on PCC activity was then examined varying the inhibitor concentration (0.5-20 lM) at a fixed concentration of propionyl-CoA. As shown in Fig. 5B , the compound inhibited the activity of the enzyme complex in a concentration-dependent manner with an IC 50 of 2.2 AE 0.2 lM. Furthermore, when the inhibitor was added to the LCC complex at a concentration of 50 lM it completely inhibited the Table 1 . Kinetic parameters of the reconstituted LCC and ACCase 5 complexes. LCC catalytic efficiency was calculated from apparent kinetic parameters assuming the molar concentration of the AccD4 subunit. Values of ACCase 5 K m and V max were obtained from Gago et al. [14] . ND, not determined.
LCC
ACCase 5 inherent PCC activity of the supercomplex, while the carboxylase activity against C 20 -CoA remained unmodified (Fig. 5C ). Together, these results have the following implications: (a) AccD5 and AccD4 recognize completely different chain-length substrates and carboxylate either short-chain acyl-CoAs (acetyl-CoA and propionylCoA) or very long-chain acyl-CoAs (≥ C 16 -CoA), respectively; (b) AccD5 appears to have a structural role, rather than a catalytic one, in the long-chain carboxylase activity of the LCC complex of M. tuberculosis, and (c) the LCC complex, formed by the AccA3, AccD4, AccD5 and AccE5 subunits, constitute a 'supercomplex' with multiple acyl-CoA carboxylase activities, and with the potentiality to produce malonyl-CoA, methylmalonyl-CoA and long-chain carboxy-acyl-CoAs, the main substrates for the biosynthesis of fatty acids, mycolic acids and other complex lipids that are relevant for the survival and/or pathogenicity of M. tuberculosis.
Accumulation of mycolic acid intermediates at suboptimal accD5-accE5 expression levels
Having established that AccD5 and AccE5 are components of an enzyme complex containing ACC, PCC and LCC activities, we investigated further the metabolic consequences that suboptimal levels of the AccD5 and AccE5 subunits have in the accD5-accE5 conditional mutant strain D5 MUT, constructed and partially analyzed in our previous work [19] . For this, we studied in more detail the lipids synthesized de novo by the mutant strain growing in the absence or presence of anhydrotetracycline (ATc), which represses accD5-accE5 expression. Lipid biosynthesis was followed by radiolabeling with [ 14 C]acetate, after shutting down the expression of both accD5 and accE5 genes during increasing times of ATc treatment (13, 16 and 19 h ) and then analyzing the labeled lipids by thinlayer chromatography (TLC). As shown in Fig. 6 , there was a clear drop in the overall mycolic acid biosynthesis and the content of the three types of mycolic acid, a, a 0 and epoxy, decreased simultaneously. This effect was accompanied by the appearance of a previously undetected spot of lipidic nature (highlighted with an X in Fig. 6A ). This spot was not present in samples obtained from the isogenic strain ISO-D5 grown in the absence or presence of ATc, suggesting that the lower levels of AccD5-AccE5 in D5 MUT are what induces the accumulation of these lipid molecules [19] . Given the retention factor (R f ) of this new spot, we could hypothesize that they were either long chain ketones or methyl esters of meromycolic acids. To differentiate between these two chemical entities we carried out a saponification reaction; the sensitivity of these molecules to this reaction suggested that they could be meromycolic esters (Fig. 6B) . Therefore, to assess whether the suboptimal level of AccD5-AccE5 provokes the accumulation of meromycolic acids in vivo, we grew the D5 MUT conditional mutant for 9-10 h in 7H9 broth, divided it into two equal aliquots and one of the aliquots was treated with ATc for 19 h (T3). Lipids were extracted from both cultures, purified and analyzed by ultra-performance liquid chromatography-quadrupole time of flight mass spectrometry (UPLC-QTOF MS). As shown in Fig. 7 , spot X corresponded most probably to a mixture of aand a 0 -meromycolic acids, precursors of the a-and a 0 -mycolic acids, and an increase in their content was clearly detected in the presence of ATc. This increment was progressive through time, supporting the idea that these long-chain fatty acids were actively synthesized and became accumulated after the decrease of the AccD5 and AccE5 subunits. The UPLC-QTOF MS analyses allowed the accurate determination of each chain length of the different types of meromycolic and mycolic acids present in the wild-type and mutant strains. The data showed that a significant drop of aand a 0 -mycolic acids occurred in the D5 MUT depleted in AccD5-AccE5, which was accompanied by an accumulation of their precursors, C 30 preexisting before shutting down accD5-accE5 expression. No epoxy-meromycolic acids were detected in either condition, suggesting that these are natural oxidation products of a-mycolic acids as proposed previously [25] . A global analysis of these experiments indicates that soon after the addition of ATc, the lower levels of AccD5-AccE5 have a negative impact in the biosynthesis of both fatty acids and mycolic acids. In principle this result could be explained by a drop in the ACC activity of the ACCase 5, as has been reported in the primary characterization of this mutant strain [19] . However, the recovery on fatty acid biosynthesis at longer incubation times after the addition of ATc would mean that malonyl-CoA biosynthesis is reestablished by a different pathway, most probably from ACCase 6, and that mycolic acid synthesis is still impaired for the lower activity of the LCC complex, where the presence of AccD5 and AccE5 plays an essential role according to our in vitro experiments. Therefore, these data show that AccD5 and AccE5 proteins play an important role in the maturation of meromycolic acids into mycolic acids.
Discussion
In the present study the successful in vitro reconstitution of the LCC complex of M. tuberculosis from its purified subunits allowed us to dissect, for the first time, the minimal subunit composition of this multimeric enzyme, as well as to unravel the role of each of the two CT subunits, AccD4 and AccD5, that form part of this complex. Previous attempts to reconstitute an active LCC from the proposed M. tuberculosis subunits resulted in almost negligible enzyme activities, likely related to the incomplete set of subunits used for the reconstitution of the enzyme complexes. For these reasons, and in order to have reliable and reproducible enzyme activities, we first optimized a direct liquid Fig. 7 . Quantitative analysis of mycolic and meromycolic acid production upon AccD5-AccE5 depletion. Mycolic acids (in methyl ester forms, i.e. MAMEs) and compound X (in free acid forms) purified from time point T3 (Fig. 6) were analyzed with respect to their chain lengths by UPLC-QTOF MS in positive and negative modes, respectively. Each mycolic acid (MA) and its corresponding meroMA are superimposed (based on the major a-branch size of C 24 ). The chain lengths indicated are those of the free MAs and meromycolic acids. The same weight of total lipids was injected for samples from accD5-accE5-expressing bacteria (accD5-E5 ON; without ATc) and AccD5-AccE5-depleted bacteria (accD5-E5 OFF; with ATc). Note that differences between AccD5-AccE5-depleted samples and control samples are minimized because molecules present before stopping accD5-accE5 expression are also detected. Results are the means of three independent experiments AE standard deviation (n = 3).
chromatography-electrospray ionization mass spectrometry (LC-ESI-MS) methodology that let us identify the products of the reaction, and then carry out UV quantification of the products of the enzymatic reaction.
One of the first conclusions that emerged from our enzyme reconstitution experiments was that the four protein subunits that were either copurified or immunoprecipitated as part of a proposed C. glutamicum or M. tuberculosis LCC complex in previous experiments [20] [21] [22] were in fact essential to reconstitute an active long-chain acyl-CoA carboxylase with activity levels 500-fold higher than a previously reconstituted LCC complex [23] . These in vitro results carried out with purified proteins of the complex also confirm a series of indirect evidence, biochemical and genetic, that suggested that two different CT subunits would be needed in order to have a fully active LCC enzyme complex. Thus, the putative presence of two different CT subunits as part of the LCC enzyme complex in mycobacteria was another interesting and in some ways conflicting issue to resolve. The main question about this result is why AccD5, the CT subunit of a carboxylase complex (together with AccA3 and AccE5) that only recognizes acetyl-CoA and propionyl-CoA as substrates in vitro [14] , would also be necessary in a more complex enzyme structure that carboxylates much larger and hydrophobic acylCoAs, such as the C 24-26 -CoA of M. tuberculosis. Considering that the crystal structure of the stable oligo hexameric AccD5 reveals an acyl-CoA binding pocket with high similarity in size and shape to the PccB active site of the propionyl-CoA carboxylase of Streptomyces coelicolor (an organism that does not synthesizes long-chain carboxy-acyl-CoAs), and with no space to accommodate a long-chain acyl group in its active site [24, 26] , it is difficult to imagine that AccD5 plays a catalytic role, together with AccD4, in the carboxylation of long-chain acyl-CoAs. On the other hand, the possibility of these two b subunits forming hetero-hexamers with a new active site on their interacting amino acid residues is less probable considering the high stability of the homo-hexamers of both subunits in solution (Fig. 1B) . Therefore, we could speculate that AccD5, together with AccE5, plays a structural role in relation to the long-chain carboxylase activity of the LCC complex, probably by stabilizing the interactions of AccD4 with AccA3 and/or determining a correct positioning of AccD4 to interact with its substrate and the carboxyl-biotin arm of AccA3.
The substrate competition experiments carried out in the presence of C 20 -CoA and propionyl-CoA, and the use of the specific AccD5 inhibitor D5-6, which only inhibited the PCC activity and not the LCC activity, strongly suggest that each CT subunit independently carboxylates its corresponding substrate within the LCC enzyme complex. However, a consideration to bear in mind in the enzyme activity experiments carried out with the four subunits that form the LCC complex is the possibility that the LCC and the PCC complexes coexist in equilibrium as two independent functional entities. In this situation, the LCC would carboxylate both short-and long-chain acyl-CoAs while the PCC complex would exclusively react with short acyl-CoAs. However, a titration of the AccA3 subunit with different concentrations of AccD4 (with ratios from 1 to 4 AccD4 with respect to AccA3 and AccD5), which should result in a shift of the equilibrium towards the LCC complex, did not increase the specific activity in the presence of C 20 -CoA (Fig. 3A) . This result implies that 1 : 1 : 1 : 2 (AccA3 : AccD4 : AccD5 : AccE5) is the minimal subunit composition that gives optimal activity against the C 20 -CoA and infers that all (or most of) the subunits form part of the LCC complex. This is also in good agreement with other in vivo experiments that show that AccD4 strongly interacts with AccD5 and with AccA3 [22] . More recently, protein-protein interaction experiments, carried out with purified a, b and e subunits from M. tuberculosis, confirmed the previous interaction data centered on the AccD4 subunit, and extended the interactome to the e subunit, suggesting a mycobacterial holocomplex analogous to the C. glutamicum LCC complex, and formed by the mycobacterial AccD4, AccD5, AccA3 and AccE5 subunits [15] .
Considering that C 24 and C 26 are the main a-alkyl branch of the mature mycolic acids of M. tuberculosis, we expected that C 24 -CoA would have been the best substrate for the LCC enzyme. However, the enzymatic assays demonstrated that C 20 -CoA was a much better substrate. This result is difficult to explain, particularly because we demonstrated that a larger C 24 -CoA does not inhibit the enzyme activity against the C 20 -CoA. We could speculate that in vitro C 24 -CoA is not readily available to the enzyme as a substrate because of its very low critical micellar concentration and that it might need a carrier for its transfer and presentation to the enzyme within the cell. Recently, the mycobacterial EchA6 protein was shown to be a shuttle of long-chain acyl-CoAs, possibly for the type II fatty acid synthase system [27] ; one can imagine that this mechanism might also serve for other metabolic complexes that also use very long-chain fatty acylCoAs as substrates, such as the LCC complex. The low K m determined for the C 20 -CoA, 10-and 5-fold lower than the values obtained for acetyl-CoA and propionyl-CoA, respectively, is coherent with the low concentration of the very long-chain acyl-CoAs found within mycobacterial cells [28] . Yet, the catalytic efficiency of the LCC complex is between 10-and 50-fold lower than the ACC and PCC activities of the same complex, respectively, probably reflecting the lower need for very long-chain carboxy-acyl-CoAs with respect to malonyl-CoA and methylmalonyl-CoA that are required for an array of fatty acid elongation pathways in mycobacteria. Recently, a novel single-chain, multi-domain biotin-dependent long-chain acyl-CoA carboxylase has been characterized in bacteria [29] . This enzyme has been named as an LCC for its preference for long-chain acyl-CoA substrates; however, it also carboxylates short-chain and medium-chain acylCoAs. The holoenzyme is a homo-hexamer and the crystal structure of the long-chain acyl-CoA carboxylase holoenzyme from Mycobacterium avium subspecies paratuberculosis revealed an architecture that is strikingly different from those of related biotin-dependent carboxylases [30] .
Our work provides conclusive evidences regarding the essential subunits that form a key ACCase complex of M. tuberculosis, the so-called long-chain acyl-CoA carboxylase. The data converge towards a model where the LCC enzyme would correspond to a supercomplex that contains all the enzymatic activities needed to synthesize the main substrates, malonyl-CoA, methylmalonyl-CoA and carboxy-C 24-26 -CoA, used by the different fatty acid synthases or polyketide synthases to produce the lipid pathogenicity factors that compose the protective coat of M. tuberculosis. Further structural analyses will be required to draw a precise picture of the topology of the unique mycobacterial LCC complex.
Material and methods
Bacterial strains, culture and transformation conditions
Escherichia coli strain DH5a [31] was used for routine subcloning and was transformed according to ref. [32] . The transformants were selected on LB medium supplemented with the appropriate antibiotics: 50 lg kanamycinÁmL À1 and/or 20 lg cloramphecnicholÁmL À1 . Mycobacterium smegmatis mc 2 155 is an electroporation proficient mutant of mc 2 6 [33] . Liquid cultures of the M. smegmatis accD5-accE5 conditional mutant D5 MUT and the isogenic strain ISO-D5 [19] were grown at 37°C in Middlebrook 7H9 medium supplemented with glycerol and the appropriate antibiotics at the following concentrations: kanamycin 15 lgÁmL
À1
, apramycin 50 lgÁmL À1 and streptomycin 10 lgÁmL
. The same antibiotic concentrations were used in solid LB medium. To repress accD5-accE5 expression, we grew the D5 MUT conditional mutant for 9-10 h in 7H9 broth, divided it into equal aliquots and treated each of them with 200 ngÁmL À1 anhydrotetracycline (ATc) for 13 h (T1), 16 h (T2) and 19 h (T3).
DNA manipulations and plasmid construction
Isolation of plasmid DNA, restriction enzyme digestion and agarose gel electrophoresis were carried out by conventional methods [32] .
Expression, purification and protein methods
Recombinant M. tuberculosis His-tagged ACCase subunits AccA3, AccD5, AccD4 and AccE5 were expressed heterologously in E. coli and purified as described to yield > 95% pure protein [14] . Proteins were analysed by SDS/PAGE [34] . Protein contents were determined by measuring A 280 nm and/or using a Quant-iT TM Protein Assay Kit and Qubit Ò fluorometer (Invitrogen, Carlsbad, CA, USA).
Size exclusion chromatography
Molecular mass was estimated by size exclusion chromatography using an € AKTA basic high-performance liquid chromatograph (GE Healthcare Life Sciences, Pittsburgh, PA, USA). Samples containing 200 lg of AccD5 or AccD4 were loaded onto a Superdex S200 column (GE Healthcare). The column was equilibrated in 50 mM potassium phosphate, pH 7.6, 50 mM NaCl and 0.5 mM DTT and eluted with the same buffer. Absorbance at 280 nm was recorded. The column was calibrated with the following molecular mass standards: blue dextran, 2000 kDa; thyroglobulin, 669 kDa; apoferritin, 443 kDa; b-amylase, 200 kDa; alcohol dehydrogenase, 150 kDa; bovine serum albumin, 66 kDa; and lysozyme, 14.3 kDa.
ACCase enzyme assays
Pyruvate kinase-lactate dehydrogenase assay
The rate of ATP hydrolysis by biotin carboxylase was measured spectrophotometrically [35] . The production of ADP was coupled to pyruvate kinase and lactate dehydrogenase, and the oxidation of NADH was monitored at 340 nm [36] . Assays were performed in a Synergy2 microplate reader (Bio-Tek Instruments, Winooski, VT, USA) as previously described [13] . Under the assay conditions described, the reaction was linear for at least 3 min and the initial rate of reaction was proportional to the enzyme concentration. Initial velocities were obtained from initial slopes of the recorder traces. One unit of enzyme activity catalyses the formation of 1 mmol of the respective carboxylated CoA derivative or ADP per minute under the of total lipids of each sample was applied on a high-performance thin layer chromatography on a silica gel 60 plate (Merck) with an ATS4 system (Camag, Muttenz, Switzerland) and developed in dichloromethane with an automatic developing chamber (ADC2; Camag). The lipids of interest were scraped off and eluted from silica gel with diethyl ether. Mero-MAMEs were further saponified in 2-methoxymethanol/KOH 5%, at 110°C for 4 h and the resulting meromycolic acids were extracted with diethyl ether, washed with water and dried. The molecules of the different samples were then separated and analyzed according to their chain length by UPLC-QTOF. Aliquots of 5 lL were injected and separated over an Acquity UPLC C18 1.7 lm column (Waters, Milford, MA, USA) using an isocratic gradient at a flow rate of 0.1 mLÁmin À1 (Acquity System; Waters). Molecules were detected using a mass spectrometer QTOF Xevo G2 (Waters), in a positive mode for MAMEs and in a negative mode for meromycolic acids. Each molecule was quantified by integration of the peak area.
